Multiple sclerosis and its primary animal model, experimental autoimmune encephalomyelitis (EAE), are inflammatory diseases of the central nervous system (CNS) characterized by immunemediated demyelination and neurodegeneration that may be mediated by inhibition of the nuclear factor-κB (NF-κB) signaling pathway. Gpr97, encoded by Adgrg3, has been reported to regulate the activity of NF-κB. In this study, using a previously established Adgrg3-knockout mouse model, we investigated the roles of Gpr97 in the development of autoimmune CNS disease in mice. We found a marked increase in the expression of Adgrg3 in spinal cords of mice with EAE. Adgrg3-deficient (Adgrg3 −/− ) mice with EAE exhibited increases in peak severity and the cumulative disease score compared with littermate controls, followed by a notable increase of leukocyte infiltration and more extensive demyelination. The percentages of Th1/Th17 cells in the CNS were significantly increased in Adgrg3 −/− mice and accompanied by high levels of interleukin (IL)-6, interferon-γ, tumor necrosis factor-α, and IL-17. An in vitro culture assay verified that Gpr97 regulated proinflammatory cytokine production. Taken together, our results show that Gpr97 plays an important role in the development of EAE and may have a therapeutic potential for the treatment of CNS autoimmunity.
Introduction
Multiple sclerosis (MS) is a complex autoimmune disease involving demyelination of the central nervous system (CNS), which affects 2.5 million people worldwide [1] . It is thought to be initiated by an acute autoimmune inflammatory reaction to myelin components, and then progresses into a chronic phase in which oligodendrocytes, myelin, and axons degenerate [2] [3] [4] . Experimental autoimmune encephalomyelitis (EAE) with pathological and clinical similarities to MS is the most characterized and widely used animal model to investigate the mechanisms of MS and develop therapies for the treatment of MS [5] . Overactivation of CD4 + T cells, especially the Th1 and Th17 subpopulations, is generally accepted as the direct cause of this disease [6] [7] [8] . EAE is induced in rodents by immunization with myelin peptides, myelin oligodendrocyte glycoprotein (MOG) or myelin proteolipid protein, in the context of complete Freund's Adjuvant (CFA) [9, 10] . In EAE, the integrity of the bloodbrain barrier decreases, allowing perivascular infiltration of the CD4 + T cells into the CNS, which leads to the infiltration and accumulation of macrophages and dendritic cells, as well as activation of glia cells, which finally causes demyelination, axonal damage, impaired nerve conduction, and paralysis [11] [12] [13] [14] . However, the etiology of EAE and MS is still unclear.
G protein-coupled receptors (GPCRs) are the largest receptor superfamily, and their participation in mediating biological processes and involvement in many diseases have been reported broadly [15] . Many GPCRs mediate the pathogenesis of MS and EAE, including antigen presentation, cytokine production, and T cell differentiation, proliferation, and invasion [16, 17] . Gpr97, a type of adhesion GPCR [18] , has a classical adhesion GPCR structure, with seven transmembrane helices, an N-terminal fragment and a Cterminal fragment that arise from autoproteolytic cleavage at a GPCR-proteolytic site, embedded in a juxtamembranous GPCR autoproteolysis-inducing domain [19, 20] . Gpr97 is expressed on leukocytes, such as neutrophils, eosinophils, and mast cells [21] , which plays roles in macrophage-related inflammation and obesityinduced metabolic syndrome [22] . Gpr97 has also been reported to be expressed in spinal cord endothelial cells from naive mice, and upregulated in spinal cord-infiltrating CD4 + T cells and spinal cord endothelial cells at peak of disease from MOG-immunized mice [23] . In our previous study, we found that Gpr97 plays an indispensable role in regulating B cell fate, especially in regulating constitutive cAMP response element-binding protein and nuclear factor (NF)-κB activities [24] . The microarray analysis of gene in brain tissue of MS patients has manifested a positive correlation with NF-κB [25, 26] . Moreover, NF-κB-deficient mice are significantly protected from EAE [27] . These findings indicate that Gpr97 might function in the development of EAE.
In the present study, we found upregulation of Adgrg3 in the spinal cord of EAE mice. Furthermore, Adgrg3 −/− mice developed significantly exacerbated EAE compared with wild-type (WT) mice. Remarkably, Gpr97 expression influenced T cell differentiation and the cytokine profile of the spinal cord and spleen tissues. Our results strongly suggest that Gpr97 plays a major role in EAE and may be a potential therapeutic target for autoimmune CNS disease.
Materials and Methods

Ethics statement
All research protocols involving animal experiments were approved by the Institutional Animal Care and Use Committee of Shanghai Research Center for Model Organisms.
Adgrg3-knockout mice
Adgrg3
−/− C57BL/6 × 129 mice were generated by Shanghai
Research Center for Model Organisms (Shanghai, China) as described previously [24] . Briefly, the mutant mice were generated by using a homologous recombination method and exons 1-2 were replaced with a neomycin cassette. The mutant mice were backcrossed to the C57BL/6 background for at least three generations before use in this study. Sex-matched Adgrg3 −/− and WT littermates at the age of 8-10 weeks were used in all experiments.
EAE induction
WT and Adgrg3 −/− female mice (8-10 weeks old, weighing 18-20 g)
were immunized subcutaneously at two sites in the flank with 300 μg MOG peptide (MEVGWYRSPFSRVVHLYRNGK; GL Biochem, Shanghai, China) dissolved in distilled water and emulsified with an equal volume of CFA (Chondrex, Redmond, USA) containing 5 mg/ml mycobacterium tuberculosis H37Ra. All animals were injected intraperitoneally at Days 0 and 2 with 200 ng Pertussis toxin (PTX; Merck, Billerica, USA) in 200 μl phosphatebuffered saline (PBS). They were weighed daily and assessed for clinical signs of EAE by two independent observers. Clinical signs of EAE were assessed daily with a 0-6 scoring system (0, no disease; 1, flaccid tail; 2, impaired righting reflex and/or gait; 3, partial hind limb paralysis; 4, complete hind limb paralysis; 5, hind limb paralysis with partial forelimb paralysis; 6, moribund or dead) [28] . 
Histology and immunofluorescence analysis
MOG-induced EAE mice were anesthetized on Day 15 and perfused with PBS followed by 4% (w/v) paraformaldehyde in PBS. Spinal cords were removed and fixed in 4% (w/v) paraformaldehyde overnight. Paraffin-embedded sections of the spinal cord were stained with hematoxylin and eosin (H&E; Solarbio, Beijing, China) or Luxol fast blue (GenMed, Shanghai, China) for the analysis of inflammation and demyelination, respectively. The number of inflammatory foci and area of demyelination were assessed as previously described [29] . Frozen sections of spinal cord were incubated for 10 min in PBS containing 0.25% Triton X-100 and blocked for 30 min in 1% bovine serum albumin/PBS. Then, the sections were labeled overnight at 4°C with a rat anti-mouse CD4 Ab (BD Biosciences, San Jose, USA). After being washed with PBS, sections were incubated for 1 h at room temperature with an Alexa Fluor 488-conjugated goat anti-rabbit secondary Ab (Invitrogen, Carlsbad, USA). After additional washes, the sections were counterstained with 4,6-diamidino-2-phenylindole and mounted in fluorescence mounting medium (Dako, Glostrup, Denmark). Images were captured under a laserscanning confocal microscope (FluoView FV10i; Olympus, Tokyo, Japan).
Isolation of CNS infiltrates
After anesthetization, mice were perfused with PBS through the left cardiac ventricle. Spinal cords and brains were isolated and homogenized in ice-cold tissue grinders and then filtered through a 70-mm cell strainer. The cells were collected by centrifugation at 500 g for 10 min at 4°C. Cells were resuspended in 8 ml of 37% Percoll (GE Healthcare UK Ltd, Buckinghamshire, UK) and centrifuged onto 4 ml of 70% Percoll cushion in 15-ml tubes at 780 g for 25 min at 25°C. Cells at the 37%-70% Percoll interface were collected and subject to flow cytometric analysis.
Flow cytometry
For surface antigen staining, cells were incubated with fluorescent dyelabeled surface Abs against CD45, CD4, CD8, B220, F4/80, Gr-1, CD5, or CD1d for 30 min at 4°C. For intracellular cytokine staining, collected cells were stimulated for 4 h at 37°C with eBioscience™ Cell Stimulation Cocktail plus protein transport inhibitors (eBioscience, San Diego, USA). The cells were first stained with the anti-CD4 Ab, permeabilized using a Cytofix/Cytoperm kit (BD Pharmingen, New Jersey, USA), and then stained with anti-interferon (IFN)-γ (eBioscience) and anti-interleukin (IL)-17A (BD Pharmingen) Abs. Stained cells were analyzed with a flow cytometer (BD FACSAria; BD Biosciences). Data were assessed using CellQuest software (BD Biosciences).
Real-time polymerase chain reaction
Total RNA was extracted from spinal cords and cultured splenocytes using Trizol reagent (Invitrogen) according to the manufacturer's instructions. The RNA was reverse transcribed using a PrimeScript RT reagent kit with gDNA eraser (Takara, Dalian, China). Real-time polymerase chain reaction (PCR) was performed with a Mastercycler ep realplex (Eppendorf, Hamburg, Germany) using the double-stranded DNA-specific fluorophore SYBR Green (Takara). Expression values were normalized to expression of housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The primers pairs are listed in Table 1 .
Splenocyte culture
WT and Adgrg3
−/− mice were sacrificed at Day 10 postimmunization. Single cell suspensions collected from spleen were cultured in 24-well plates at 4 × 10 6 cells in 2-ml medium per well and stimulated with medium alone or with 20 μg/ml MOG peptide for 48 h. Splenocytes and culture supernatants were assessed for cytokine levels by real-time PCR and ELISA, respectively.
Measurement of cytokine production
Concentrations of selected cytokines, IL-6, tumor necrosis factor (TNF)-α, IFN-γ, and IL-17A, in the culture supernatants of splenocytes were measured by ELISA using commercial kits (Biolegend, San Diego, USA) according to the manufacturer's recommendations.
Statistical analysis
Results are presented graphically as the mean ± standard error of the mean (SEM). Statistical differences were assessed by one-way analysis of variance. A value of P < 0.05 was considered as statistically significant.
Results
Adgrg3 is expressed during EAE and affects disease severity
To explore the role of Gpr97 in MS pathogenesis, spinal cords were collected from C57BL/6 mice immunized with MOG in CFA together with PTX at various disease stages and subject to quantitative real-time PCR analysis. At peak of disease (15 days after MOG immunization), the mRNA level of Adgrg3 was markedly increased in the spinal cords of C57BL/6 mice (Fig. 1A ). Subsequently, Adgrg3 mRNA level was decreased with remission of neurological symptoms 25 days after immunization (Fig. 1A) . To test the hypothesis that Gpr97 might be involved in the pathogenesis of EAE, Adgrg3 −/− mice and WT controls were subject to MOG immunization. Compared with WT mice, MOG-immunized Adgrg3 −/− mice developed more severe EAE symptoms including significant increases in the peak severity and cumulative disease score ( Fig. 1B and Table 2 ). To further evaluate the pathological severity in the CNS of Adgrg3 −/− and WT mice subjected to EAE, the spinal cord was stained with H&E and Luxol fast blue at Day 15 after immunization. Areas of inflammation ( Fig. 2A,B) and demyelination (Fig. 2C , D) in Adgrg3 −/− mice were more widespread compared with those Table 1 . Primers used in this study Data are expressed as the mean ± SEM and representative of at least two independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001).
in WT mice, which were consistent with their increased clinical scores. These data demonstrated that Gpr97 plays a critical role in controlling the disease severity.
CD4
+ and CD8 + T cells are increased in the spinal cord of Adgrg3 −/− mice with EAE
To characterize the population of lymphocytes that had infiltrated into the CNS, mononuclear cells isolated from spinal cords of the mice at the peak of disease were subject to flow cytometric analysis by using lineage-specific cell-surface markers. The results showed that the percentages of F4/80 + , Gr-1 + , and B220 + cells were comparable between WT and Adgrg3 −/− mice, but CD4 + and CD8 + T cells were significantly increased in Adgrg3 −/− mice (Fig. 3A,B ).
Immunofluorescence staining with an anti-CD4 Ab confirmed the increase in the number of CD4 + T cells in the spinal cord of (Fig. 3C) . CD8 + T cells were rarely detected in WT and Adgrg3 −/− mice by immunofluorescence (data not shown).
Thus, CD4
+ T cells were the main lymphocytes that had infiltrated into the CNS of Adgrg3 −/− mice.
Gpr97 deficiency increases serum levels of MOG-specific IgM and IgG production
Serum levels of MOG-specific IgM and IgG were assessed on Day 15 (peak phase) and Day 25 (recovery phase) after MOG immunizations, because MOG-specific Abs can enhance CNS demyelination and inflammation and increase EAE severity [29] . Serum MOGspecific IgM production in WT mice with EAE was significantly increased compared with unimmunized littermates at Day 15 after immunization, but decreased significantly at Day 25 (Fig. 4A) . In addition, the serum level of MOG-specific IgG in WT mice with EAE was significantly elevated compared with that in unimmunized littermates 15 and 25 days after immunization (Fig. 4B) . The serum levels of MOG-specific IgM and IgG were increased significantly in Adgrg3 −/− mice with EAE compared with those in WT mice without MOG immunization (Fig. 4A,B) . When compared with that in WT mice with EAE, the serum level of anti-MOG IgG in Adgrg3 −/− mice was markedly increased at Day 15 after immunization (Fig. 4B) , which correlated with the increase in EAE severity of Adgrg3 −/− mice. Serum levels of anti-MOG-specific IgM were similar in WT and Adgrg3 −/− mice. These data indicated that Gpr97 deficiency dramatically accelerates MOG-specific IgG production in EAE.
Gpr97 deficiency alters the cytokine production in the spinal cord at peak of disease
To investigate the immunological mechanisms associated with the elevated severity of EAE in Adgrg3 −/− mice, spinal cords were harvested from WT and Adgrg3 −/− mice 15 and 25 days after MOG immunization to assess cytokine expression by real-time PCR. As shown in Fig. 5A , mRNA expression of Th1 cytokine IFN-γ was increased in Adgrg3 −/− mice compared with that in WT mice, but the IL-12 mRNA expression level was not altered significantly. mRNA expression of TNF-α, a proinflammatory cytokine, in Adgrg3 −/− mice was markedly increased compared with that in WT mice. IL-6 and IL-17 mRNA expression levels were also increased in Adgrg3 −/− mice. In contrast, the mRNA level of IL-10, a Th2 cytokine, in Adgrg3 −/− mice was comparable to that in WT mice.
However, there was no significant difference in the expression of these cytokines between Adgrg3 −/− and WT mice at Day 25 after immunization (Fig. 5B) . We next determined which kind of immune cells is regulated by Gpr97 during EAE pathogenesis. Because it is widely accepted that Th1 and Th17 cells are the main pathological T cells involved in EAE development [29] , we examined cytokine expression in CNS-infiltrating CD4 + T cells 15 days after MOG immunization. The percentages of IFN-γ-and IL-17-expressing cells were augmented in Adgrg3 −/− mice compared with those in WT mice (Fig. 5C,D) . Taken together, these data demonstrated that, in accordance with the elevated disease scores, Adgrg3 −/− mice exhibit an increase in the infiltration of IFN-γ-and IL-17-producing CD4 + T cells into the CNS at the peak of disease.
Gpr97 deficiency does not influence regulatory IL-10-producing CD1d hi CD5 + (B10) cells in the spleen
We next investigated the peripheral immune cell composition in the spleens of Adgrg3 −/− and WT mice by flow cytometry at peak of disease.
The percentage of CD8 + T cells in Adgrg3 −/− mice was equivalent to that in WT mice, while significant increases in CD45 + and CD4 + cells at the peak of disease were observed in Adgrg3 −/− mice (Fig. 6A,B) .
Studies have demonstrated that IL-10 from B cells is important for EAE recovery. The B10 cell population inhibits the induction of antigen-specific inflammatory reactions [30, 31] . Based on these reports, we compared B10 cells between Adgrg3 −/− and WT mice.
Splenocytes were isolated from Adgrg3 −/− and WT mice at Day 15, and subject to flow cytometric analysis. The results revealed that the B10 cell population in the spleens of Adgrg3 −/− mice was comparable to that of WT littermates (Fig. 6C,D) . Thus, the B10 cell population was not influenced in Adgrg3 −/− B cells.
Gpr97 alters the cellular phenotype in vitro
We also examined whether Gpr97 influences the production of cytokines from splenocytes ex vivo. Adgrg3 −/− and WT mice with EAE were sacrificed at Day 10 post-immunization. Spleens were collected and single cell suspensions were cultured in the presence or absence of MOG for 48 h. The cells were then harvested and analyzed by real-time PCR for IL-6, TNF-α, IL-17, and IFN-γ mRNA expression. It was found that the mRNA levels of IL-6, TNF-α, and IFN-γ were significantly increased in Adgrg3 −/− splenocytes from EAE mice (Fig. 7A) , but the mRNA level of IL-17 exhibited no significant change in Adgrg3 −/− splenocytes compared with that in WT mice.
Furthermore, culture supernatants were collected and the amounts of IL-6, TNF-α, IL-17, and IFN-γ were determined by ELISA. As shown in Fig. 7B , the concentrations of TNF-α, IFN-γ, and IL-17 were increased dramatically in Adgrg3 −/− mice in the presence of MOG compared with those in WT mice. However, no obvious change in the level of IL-6 was observed in the culture supernatants of cells from Adgrg3 −/− mice. Taken together, these results demonstrated that Gpr97 deficiency might affect cytokine production in MOG-specific Th1 and Th17 cells.
Discussion
As an inflammatory demyelinating disease of the CNS, MS is one of the foremost causes for non-traumatic neurological disability in young adults [10, 32] . However, the pathogenesis of MS is still unclear, and new therapeutic drug targets need to be identified for MS [33] . The superfamily of GPCRs has diverse structures and functions, which broadly participates in biological processes and are involved in many human diseases [10] . Numerous GPCRs, such as prostaglandin E 2 receptors EP2 and EP4 [34] , AngII type 1a receptor [35] , and kinin receptor B1 [36] , have been reported to mediate the pathogenesis of MS and EAE.
In the present study, we assessed the role of Gpr97 in the induction and recovery of EAE using a previously established knockout (KO) mouse model. Human GPR97 belongs to a family of adhesion GPCRs that have been confirmed to play important roles in the central nervous system, the immune system and tumor formation [37] . Gpr97 expressed in immune cells and lymphatic endothelial cells contributes to cytokine release and cell migration [38] . Hence, we hypothesized that it may play a regulatory role in the autoimmune disease of EAE. In our study, we demonstrated that Gpr97 plays a critical role in the pathogenesis of EAE induced by MOG peptide. Our data showed that Gpr97 loss resulted in increases of the clinical and pathological severities of the disease. Adgrg3 −/− mice with EAE showed increases in the infiltration of CD4 + T cells into the inflamed CNS. In addition, Adgrg3 −/− mice with EAE showed an increased serum anti-MOG-specific IgG level at the peak phase, while the level of anti-MOG-specific IgM was unaltered. Furthermore, cytokine expression profiles were changed both in vivo and in vitro. Therefore, Gpr97 deficiency modified the disease manifestation of EAE.
As shown in Fig. 1A , a sharp increase in the mRNA expression of Adgrg3 in the spinal cords of C57BL/6 mice was found at Day 15 after immunization. In EAE, the infiltration of the CD4 + T cells into the CNS leads to the infiltration and accumulation of macrophages and dendritic cells, and astrocytes and microglia activation are a few critical steps [39] . A microfluidic-based GPCR expression analysis of different cell types implicated in the pathogenesis of human MS and its mouse model EAE has shown that Gpr97 is expressed in spinal cord endothelial cells from naive mice, and upregulated in spinal cord-infiltrating CD4 + T cells and spinal cord endothelial cells at peak of disease from MOG-immunized mice, but not expressed in CD11b-positive cells obtained at peak of disease from MOGimmunized mice, which consisted of two subpopulations: macrophage and microglia [23] . Thus, the increased mRNA expression level of Adgrg3 in the spinal cords from EAE mice is related to the upregulated expression of Gpr97 in endothelial cells and infiltrated Gpr97-expressing CD4 + T cells.
It is well documented that NF-κB signaling pathway is involved in encephalitogenic T cell activation. NF-κB activation is observed in the brains of MS patients and spinal cords of EAE mice [40, 41] . NF-κB-deficient mice have been reported to be significantly protected from EAE, which is associated with an abnormal differentiation of myelin-specific T cells into either Th1-or Th2-type effector cells in vivo [27] . These data demonstrate a key role of NF-κB in EAE development. Our previous observation that Gpr97 deficiency leads to increased constitutive expression and activation of NF-kB pathway components prompted us to investigate the potential role of Gpr97 in the development of EAE. Here, we found that Adgrg3 −/− mice developed more severe inflammation, followed by notably increased areas of inflammation and demyelination.
Our previous report suggested a role of Gpr97 in B cell development [24] . The importance of B cells in EAE has been reported, which leads to new insights into B cell functions in human pathogenesis and a focus on the development of B cell therapeutics [42, 43] . Both congenitally B cell-and CD19-deficient mice with reduced B cell functions developed severe EAE, but failed to remit the disease, suggesting a regulatory role for B cells, most likely in association with B10 cells [30, 44] . In this study, we investigated the differences in B10 cells between Adgrg3 −/− and WT mice. We observed comparable percentage of B10 cells in both Adgrg3 −/− and WT mice, indicating that Gpr97 deficiency does not affect B10 cell development. MOG-specific Abs enhance CNS demyelination and inflammation, leading to an increase in the severity of EAE [7] . Additionally, plasma exchange attenuates the clinical disease activity in a subset of MS patients [45, 46] , indicating that many factors play major roles in MS and EAE. The serum anti-MOG IgG level was markedly increased 15 days after immunization in the current study, which correlated with the increased EAE severity of Adgrg3 −/− mice.
In conclusion, in the present study, we demonstrated that Gpr97 expression is involved in the development of EAE, and regulates T cell differentiation and cytokine profiles of the spinal cord and spleen tissues. Thus, modulation of Gpr97 functions or its pathway may be a potential therapeutic strategy against autoimmune CNS disease.
